
Terra Innovatum shares 12 draft SOLO safety chapters with NRC
The reactor developer targets Oct. 30 for the remaining six chapters and retains its company-set 2027 deployment goal.

Fortum's jointly owned disposal company must complete commissioning and pass a STUK inspection before operations can begin.

The reactor developer targets Oct. 30 for the remaining six chapters and retains its company-set 2027 deployment goal.

New applications came in below a 200,000 forecast, while continuing claims increased by 25,000 in the Labor Department's weekly report.
The upper Hotspot results will inform geological modelling, with true widths still unestablished and some holes cut short by ground conditions.
Crews are assessing two undrilled occurrences and the corridor between them, with initial results expected in early 2027.

An independent board will review ReMEDy2 in Q1 2027 and may resize the study to as many as 728 participants or stop it for futility.

Rigs are secured for approved drilling at Aberfoyle and Great Pyramid, while separate tailings work awaits regulatory approval.

The delayed draw facility starts with US$171 million borrowed and a 180-day maturity, with an extension tied to supply agreements and lender consent.

The developer will stop internal Rejuva gene-therapy work and forecasts cash into Q2 2027, ahead of a potential 2028 launch.
The hepatitis B developer can pursue further United States testing, but has not disclosed a new trial design or start date.
The National Wealth Fund is providing £12.2 million, with admission targeted for Nov. 12 subject to shareholder approval.
Applied Digital would own 51 per cent of the project company, while prospective tenant ChronoScale has signed only a non-binding letter of intent.
Confirmed disability progression affected 11.7 per cent with continuous treatment versus 17.4 per cent after an initial comparator.
Banking and auto indexes fell while Infosys prepares to release its September quarter results on Oct. 23.
An initial study is estimated at six months; NANO disclosed no retainer amount, fabrication price or component delivery date.
The Badajoz site is planned for 2028 onwards, while the announcement leaves its construction budget and customer commitments unspecified.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
The interval also returned 0.83 per cent antimony, but true widths remain unknown after the completed 14-hole campaign.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
A 131-patient registry analysis found higher graft risk, while a separate randomized trial reported 49% fewer kidney biopsies.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
The annual profit outlook is unchanged, while higher working capital needs and restructuring reduce expected cash conversion.
Holders would receive C$0.084 cash and 0.0763 QeM shares per share, with former Plurilock owners projected to hold 4.03 per cent after closing.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Construction is underway on a commercial LEU+ factory, with listed owners Cameco and Brookfield Renewable exposed through their Westinghouse interests.

Initial civil works are complete, but the issuer disclosed no contract price, funding commitment or construction timetable.

The state and Hoosier Energy will assess sites, financing and power contracts, with no study budget or construction decision date disclosed.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
The capsules are intended for three programs, including a Canadian Phase 3 PTSD trial of up to 100 people expected to begin in 2027.

The province estimates illegal retailers take 30 per cent of cannabis sales and proposes inspection, seizure and penalty powers for the AGCO.

The bid offers US$1 in cash plus 0.4013 Curaleaf shares for each Aurora share, with a Dec. 4 tender deadline.

Cash earnouts tied to 2026 and 2027 earnings add to the base price for a grower supplying nearly all 69 shops in the Dutch pilot.